Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias

Europace

Volumn 16, Issue 10, 2014, Pages 1508-1514

  Ozcan, Cevher ^a,b   Strom, Jordan B ^a   Newell, John B ^a   Mansour, Moussa C ^a   Ruskin, Jeremy N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Ablation; Atrial fibrillation; Predictors; Supraventricular tachycardia; Survival

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CATHETER ABLATION; FEMALE; FOLLOW UP; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PR INTERVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL ANALYSIS; SURVIVAL RATE; ATRIAL FLUTTER; COMORBIDITY; COMPLICATION; INCIDENCE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SUPRAVENTRICULAR;

ATRIAL FIBRILLATION; ATRIAL FLUTTER; CATHETER ABLATION; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84920677248     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu129     Document Type: Article

References (32)

1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 2011; 123:e269-367.
2. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary. Circulation 2003;108:1871-909.
3. Lloyd-Jones DM,Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110: 1042-6.
4. Miyasaka Y, Barnes ME, Gresh BJ, Cha SS, Bailey KR, Abhayaratna WP et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114: 119-25.
5. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 2001;285:2370-5.
6. KannelWB,Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9.
7. Benjamin EJ,Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946-52.
8. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28:316-21.
9. Wang TJ, LarsonMG, Levy D, Vasan RS, Leip EP,Wolf PA et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-5.
10. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995;98:476-84.
11. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ,Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994;271:840-4.
12. Waldo AL, Feld GK. Inter-relations of atrial fibrillation and atrial flutter: mechanisms and clinical implications. J Am Coll Cardiol 2008;51:779-86.
13. Hurwitz JL, German LD, Packer DL, Wharton JM, McCarthy EA, WilkinsonWEet al. Occurrence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia due to atrioventricular nodal reentry. Pacing Clin Electrophysiol 1990; 13:705-10.
14. Hamer ME, WilkinsonWE, Clair WK, Page RL, McCarthy EA, Pritchett EL. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol 1995;25:984-8.
15. Brugada J, Mont L, Matas M, Navarro-López F. Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia. Am J Cardiol 1997;79:681-2.
16. Halligan SC, Gersh BJ, Brown RD Jr, Rosales AG, Munger TM, Shen WK et al. The natural history of lone atrial flutter. Ann Intern Med 2004;140:265-8.
17. Chinitz JS, Gerstenfeld EP, Marchlinski FE, Callans DJ. Atrila fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Heart Rhythm 2007;4:1029-33.
18. Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-77.
19. Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011;121:2955-68.
20. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26.
21. U.S. National Center for Health Statistics, National Vital Statistics Reports (NVSR). Deaths: final data for 2007, 58, May 2010. http://cdc.gov/NCHS/products/nvsr. htm#vol58.
22. Hainess DE, DiMarco JP. Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol 1990;15:1345-54.
23. Haissaguerre M, Fischer B, Labbe T, Lemétayer P, Montserrat P, d'Ivernois C et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol 1992;69:493-7.
24. Sauer WH, Alonso C, Zado E, Cooper JM, Lin D, Dixit S et al. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow pathway modification. Circulation 2006;114:191-5.
25. Katritsis DG, Giazitzoglou E, Wood MA, Shepard RK, Parvez B, Ellenbogen KA. Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation. Europace 2007;9:785-9.
26. Weiss R, Knight BP, Bahu M, Zivin A, Souza J, Goyal Ret al. Long-term follow-up after radiofrequency ablation of paroxysmal supraventricular tachycardia in patients with tachycardia-induced atrial fibrillation. Am J Cardiol 1997;80:1609-10.
27. Wyndham CR, Amat-y-Leon F,WuD, Denes P, Dhingra R, Simpson Ret al. Effects of cycle length on atrial vulnerability. Circulation 1977;55:260-7.
28. Horvath G, Goldberger JJ, Kadish AH. Simultaneous occurrence of atrial fibrillation and atrial flutter. J Cardiovasc Electrophysiol 2000;11:849-58.
29. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008;1:62-73.
30. Vaquero M, Calvo D, Jalife J. Cardiac fibrillation: from ion channels to rotors in the human heart. Heart Rhythm 2008;5:872-9.
31. Porter MJ,Morton JB,Denman R, LinAC, Tierney S, SantucciPAet al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004;1: 393-6.
32. FeinbergWM, Blackshear JL, Laupacis A, Kronmol R, Hart RG. Prevalence, age distribution, andgender ofpatients with atrial fibrillation. Arch InternMed1995;155:469-73.